Bruker Co. (NASDAQ:BRKR) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Bruker Co. (NASDAQ:BRKRGet Free Report) have been given an average rating of “Moderate Buy” by the nine analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $83.44.

BRKR has been the topic of several research analyst reports. The Goldman Sachs Group dropped their price objective on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday. Jefferies Financial Group began coverage on Bruker in a research report on Monday, June 3rd. They set a “buy” rating and a $85.00 price target on the stock. StockNews.com cut Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. Stifel Nicolaus dropped their target price on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a report on Monday, May 20th. Finally, Bank of America reduced their price target on shares of Bruker from $95.00 to $90.00 and set a “buy” rating for the company in a report on Monday, May 20th.

Read Our Latest Stock Report on BRKR

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Lindbrook Capital LLC raised its position in Bruker by 68.2% during the fourth quarter. Lindbrook Capital LLC now owns 360 shares of the medical research company’s stock worth $26,000 after acquiring an additional 146 shares in the last quarter. Baker Tilly Wealth Management LLC grew its holdings in Bruker by 3.0% during the fourth quarter. Baker Tilly Wealth Management LLC now owns 5,285 shares of the medical research company’s stock worth $388,000 after purchasing an additional 156 shares during the period. Lifestyle Asset Management Inc. increased its position in Bruker by 1.3% during the first quarter. Lifestyle Asset Management Inc. now owns 12,534 shares of the medical research company’s stock worth $1,177,000 after buying an additional 158 shares during the last quarter. Legacy Wealth Asset Management LLC raised its stake in Bruker by 5.7% in the fourth quarter. Legacy Wealth Asset Management LLC now owns 3,412 shares of the medical research company’s stock valued at $251,000 after buying an additional 184 shares during the period. Finally, Park Place Capital Corp lifted its position in shares of Bruker by 19.4% in the first quarter. Park Place Capital Corp now owns 1,139 shares of the medical research company’s stock valued at $107,000 after buying an additional 185 shares during the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Bruker Price Performance

Bruker stock opened at $61.25 on Friday. The firm has a market capitalization of $8.90 billion, a P/E ratio of 22.27, a PEG ratio of 2.10 and a beta of 1.20. The business has a 50-day moving average of $68.56 and a 200-day moving average of $76.76. The company has a current ratio of 1.81, a quick ratio of 0.91 and a debt-to-equity ratio of 0.95. Bruker has a 1 year low of $53.79 and a 1 year high of $94.86.

Bruker (NASDAQ:BRKRGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical research company reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.07. The firm had revenue of $721.70 million during the quarter, compared to analysts’ expectations of $729.88 million. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.64 earnings per share. On average, equities analysts anticipate that Bruker will post 2.66 EPS for the current year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 17th. Shareholders of record on Monday, June 3rd were given a dividend of $0.05 per share. The ex-dividend date was Monday, June 3rd. This represents a $0.20 annualized dividend and a yield of 0.33%. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

Bruker Company Profile

(Get Free Report

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Featured Articles

Analyst Recommendations for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.